Product Name: Ibrutinib (PCI-32765)Request Ibrutinib (PCI-32765)
Synonym: PCI-32765; Ibrutinib, PCI32765; PCI 32765. ,
Ibrutinib (PCI-32765) Chemical Structure
5 stars, based on 1836 reviewsIUPAC/Chemical name:
Price of Ibrutinib (PCI-32765) We offer a substantial discount on larger orders,
please inquire via firstname.lastname@example.org
or Fax: 1-201-884-1288 (USA Fax#)
Biological ActivityIbrutinib, also known as PCI-32765, is a BTK inhibitor, is also an orally bioavailable small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. BTK inhibitor PCI-32765 binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor (BCR) signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. Ibrutinib was approved by the US FDA on November 13, 2013 for the treatment of mantle cell lymphoma.
Canonical SMILES: C=CC(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O
Purchase(buy) Ibrutinib (PCI-32765) at Active Biochem
and the United State(U.S.), Germany, Japan, France,United Kingdom(UK),Switzerland, Australia distributors.